Cargando…
Effect of Hypochlorous Acid on Blepharitis through Ultrasonic Atomization: A Randomized Clinical Trial
Purpose: To evaluate the efficacy and safety of eyelid hygiene using topical 0.01% hypochlorous acid (HOCL) through ultrasonic atomization after 2 weeks in patients with blepharitis. Design: Randomized controlled trial. Methods: Patients with blepharitis were randomized into two groups: topical 0.01...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917691/ https://www.ncbi.nlm.nih.gov/pubmed/36769811 http://dx.doi.org/10.3390/jcm12031164 |
_version_ | 1784886428783607808 |
---|---|
author | Zhang, Hong Wu, Yuqing Wan, Xichen Shen, Yan Le, Qihua Yang, Pei Zhou, Shuyun Zhou, Xujiao Zhou, Feng Gu, Hao Hong, Jiaxu |
author_facet | Zhang, Hong Wu, Yuqing Wan, Xichen Shen, Yan Le, Qihua Yang, Pei Zhou, Shuyun Zhou, Xujiao Zhou, Feng Gu, Hao Hong, Jiaxu |
author_sort | Zhang, Hong |
collection | PubMed |
description | Purpose: To evaluate the efficacy and safety of eyelid hygiene using topical 0.01% hypochlorous acid (HOCL) through ultrasonic atomization after 2 weeks in patients with blepharitis. Design: Randomized controlled trial. Methods: Patients with blepharitis were randomized into two groups: topical 0.01% HOCL through ultrasonic atomization (HOCL group, 42 eyes) or eyelid scrubs (control group, 37 eyes). Patients in both groups received warm compresses twice daily and topical 0.5% levofloxacin three times a day. Primary outcomes were the ocular surface disease index scores (OSDI), lid margin redness, lid margin abnormalities, meibum expressibility, meibum quality, and noninvasive breakup time after 2 weeks. Secondary outcomes were conjunctiva redness, corneal fluorescein staining, and tear meniscus height. A questionnaire of treatment adherence with a free response section was administered to confirm patient compliance and comments. Results: Sixty-seven participants participated in this study. Both groups show an improvement in all primary outcomes, while statistically significant improvements in OSDI, lid margin redness, lid margin abnormality, meibum expressibility and quality are only limited to the HOCL group after 2 weeks of treatment (p < 0.05, p < 0.05, p < 0.001, p < 0.001 and p < 0.001, respectively). Subgroup analysis in HOCL reveals that only the change in lid margin abnormality and meibum expressibility in the mild–moderate meibomian glands loss patients at baseline has a statistically significant difference p < 0.05). Multiple linear regression shows that the improvement in OSDI is negatively associated with meibum expressibility score at the baseline (95% CI [−28.846, −1.815], p = 0.028). The patient compliance is 7.1 ± 2.0 in the HOCL group and 7.1 ± 1.8 in the control group (p > 0.05). No adverse events are reported. Conclusion: Topical 0.01% HOCL through ultrasonic atomization is a tolerable and effective eyelid hygiene treatment for blepharitis. |
format | Online Article Text |
id | pubmed-9917691 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-99176912023-02-11 Effect of Hypochlorous Acid on Blepharitis through Ultrasonic Atomization: A Randomized Clinical Trial Zhang, Hong Wu, Yuqing Wan, Xichen Shen, Yan Le, Qihua Yang, Pei Zhou, Shuyun Zhou, Xujiao Zhou, Feng Gu, Hao Hong, Jiaxu J Clin Med Article Purpose: To evaluate the efficacy and safety of eyelid hygiene using topical 0.01% hypochlorous acid (HOCL) through ultrasonic atomization after 2 weeks in patients with blepharitis. Design: Randomized controlled trial. Methods: Patients with blepharitis were randomized into two groups: topical 0.01% HOCL through ultrasonic atomization (HOCL group, 42 eyes) or eyelid scrubs (control group, 37 eyes). Patients in both groups received warm compresses twice daily and topical 0.5% levofloxacin three times a day. Primary outcomes were the ocular surface disease index scores (OSDI), lid margin redness, lid margin abnormalities, meibum expressibility, meibum quality, and noninvasive breakup time after 2 weeks. Secondary outcomes were conjunctiva redness, corneal fluorescein staining, and tear meniscus height. A questionnaire of treatment adherence with a free response section was administered to confirm patient compliance and comments. Results: Sixty-seven participants participated in this study. Both groups show an improvement in all primary outcomes, while statistically significant improvements in OSDI, lid margin redness, lid margin abnormality, meibum expressibility and quality are only limited to the HOCL group after 2 weeks of treatment (p < 0.05, p < 0.05, p < 0.001, p < 0.001 and p < 0.001, respectively). Subgroup analysis in HOCL reveals that only the change in lid margin abnormality and meibum expressibility in the mild–moderate meibomian glands loss patients at baseline has a statistically significant difference p < 0.05). Multiple linear regression shows that the improvement in OSDI is negatively associated with meibum expressibility score at the baseline (95% CI [−28.846, −1.815], p = 0.028). The patient compliance is 7.1 ± 2.0 in the HOCL group and 7.1 ± 1.8 in the control group (p > 0.05). No adverse events are reported. Conclusion: Topical 0.01% HOCL through ultrasonic atomization is a tolerable and effective eyelid hygiene treatment for blepharitis. MDPI 2023-02-01 /pmc/articles/PMC9917691/ /pubmed/36769811 http://dx.doi.org/10.3390/jcm12031164 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Zhang, Hong Wu, Yuqing Wan, Xichen Shen, Yan Le, Qihua Yang, Pei Zhou, Shuyun Zhou, Xujiao Zhou, Feng Gu, Hao Hong, Jiaxu Effect of Hypochlorous Acid on Blepharitis through Ultrasonic Atomization: A Randomized Clinical Trial |
title | Effect of Hypochlorous Acid on Blepharitis through Ultrasonic Atomization: A Randomized Clinical Trial |
title_full | Effect of Hypochlorous Acid on Blepharitis through Ultrasonic Atomization: A Randomized Clinical Trial |
title_fullStr | Effect of Hypochlorous Acid on Blepharitis through Ultrasonic Atomization: A Randomized Clinical Trial |
title_full_unstemmed | Effect of Hypochlorous Acid on Blepharitis through Ultrasonic Atomization: A Randomized Clinical Trial |
title_short | Effect of Hypochlorous Acid on Blepharitis through Ultrasonic Atomization: A Randomized Clinical Trial |
title_sort | effect of hypochlorous acid on blepharitis through ultrasonic atomization: a randomized clinical trial |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917691/ https://www.ncbi.nlm.nih.gov/pubmed/36769811 http://dx.doi.org/10.3390/jcm12031164 |
work_keys_str_mv | AT zhanghong effectofhypochlorousacidonblepharitisthroughultrasonicatomizationarandomizedclinicaltrial AT wuyuqing effectofhypochlorousacidonblepharitisthroughultrasonicatomizationarandomizedclinicaltrial AT wanxichen effectofhypochlorousacidonblepharitisthroughultrasonicatomizationarandomizedclinicaltrial AT shenyan effectofhypochlorousacidonblepharitisthroughultrasonicatomizationarandomizedclinicaltrial AT leqihua effectofhypochlorousacidonblepharitisthroughultrasonicatomizationarandomizedclinicaltrial AT yangpei effectofhypochlorousacidonblepharitisthroughultrasonicatomizationarandomizedclinicaltrial AT zhoushuyun effectofhypochlorousacidonblepharitisthroughultrasonicatomizationarandomizedclinicaltrial AT zhouxujiao effectofhypochlorousacidonblepharitisthroughultrasonicatomizationarandomizedclinicaltrial AT zhoufeng effectofhypochlorousacidonblepharitisthroughultrasonicatomizationarandomizedclinicaltrial AT guhao effectofhypochlorousacidonblepharitisthroughultrasonicatomizationarandomizedclinicaltrial AT hongjiaxu effectofhypochlorousacidonblepharitisthroughultrasonicatomizationarandomizedclinicaltrial |